Home / Companies / Catalyst Pharmaceuticals, Inc. / 21 May 2024
Catalyst Pharmaceuticals, Inc.: meeting of 21 May 2024
Votes reported on Form N-PX, item by item
414 Form N-PX filers reported votes at the Catalyst Pharmaceuticals, Inc. meeting of 21 May 2024. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
7 nominees; 95.3% of reported votes for; 14 filers withheld from or voted against at least one nominee.
2,061 vote records from 151 filers. 5 of the 151 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
719 vote records from 409 filers. 34 of the 396 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.
2 filers reported share counts too large to be the holding described. Those figures are left out of the share split below; the counts of filers include them. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
293 vote records from 149 filers. 1 of the 149 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
297 vote records from 152 filers. 5 of the 152 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
265 vote records from 133 filers. 131 of the 133 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
29 vote records from 19 filers. 14 of the 19 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Catalyst Pharmaceuticals, Inc. meeting?
414 Form N-PX filers reported votes at the meeting of 21 May 2024. On say-on-pay, 34 of 396 voted against management (8.6%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Catalyst Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Catalyst Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Catalyst Pharmaceuticals, Inc. with a meeting date within three days of 21 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.